SavedAdd your journal

Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 10

Investigation of premenstrular dysphoric disorder comorbidity and related factors in patients with anxiety disorder

Gokhan Acmaz
Faruk Uguz
Huda Murat Soyak
Pages
1870–1876
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: PMDD is common in patients followed up with a diagnosis of anxiety disorder and what is associated with PMDD is be young age as well as excessive chocolate consumption.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Because of the fact that the frequency of both anxiety disorders and premenstrual dysphoric disorder (PMDD) are high in women and that studies investigating PMDD comorbidity in patients diagnosed with anxiety disorder are limited, this study was aimed to investigate PMDD comorbidity and related factors in patients with anxiety disorders.
📊
Key Findings & Data:Materials and Methods: 183 subjects who were followed up with a diagnosis of anxiety disorder in Necmettin Erbakan University Meram Medical Faculty Psychiatry Outpatient Clinic were included in the study and were evaluated with Sociodemographic Data Form, Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI).
💡
Conclusion & Impact:Conclusion: PMDD is common in patients followed up with a diagnosis of anxiety disorder and what is associated with PMDD is be young age as well as excessive chocolate consumption.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Because of the fact that the frequency of both anxiety disorders and premenstrual dysphoric disorder (PMDD) are high in women and that studies investigating PMDD comorbidity in patients diagnosed with anxiety disorder are limited, this study was aimed to investigate PMDD comorbidity and related factors in patients with anxiety disorders. Materials and Methods: 183 subjects who were followed up with a diagnosis of anxiety disorder in Necmettin Erbakan University Meram Medical Faculty Psychiatry Outpatient Clinic were included in the study and were evaluated with Sociodemographic Data Form, Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI). PMDD comorbidity was investigated according to The Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV-TR) criteria by making psychiatric interviews. Results: 57 (31.2%) of 183 subjects diagnosed with PMDD constituted the PMDD group and the remaining 126 patients constituted the non-PMDD group. The mean BAI scores of the PMDD group were significantly higher than those of the non PMDD group, whereas the mean age of the PMDD group was significantly lower than that of the non PMDD group. The BMI of the PMDD group was significantly higher than that of the non PMDD group. Conclusion: PMDD is common in patients followed up with a diagnosis of anxiety disorder and what is associated with PMDD is be young age as well as excessive chocolate consumption.

🔖

Cite This Article

Acmaz, G., Uguz, F., Soyak, H. M. (2022). Investigation of premenstrular dysphoric disorder comorbidity and related factors in patients with anxiety disorder. Annals of Medical Research, Cilt: 28 - Sayı: 10, 1870–1876. https://ajindex.com/articles/445894

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Dennerstein L, Lehert P, Heinemann K. Epidemiology of premenstrual symptoms and disorders. Menopause Int 2012;18:48-51
  2. Biggs WS, Demuth RH. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician 2011;84:918-24
  3. American Psychiatric Assosiation. Diagnostic and Statistical Manual of Mental Disorders Third Edition (DSMIII-R). Washington DC: American Psychiatric Assosiation, 1987
  4. American Psychiatric Assosiation. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV). Washington DC: American Psychiatric Assosiation, 1994
  5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V). Washington DC: American Psychiatric Association; 2013
  6. Miyaoka Y, Akimoto Y, Ueda K, et al. Fulfillment of the premenstrual dysphoric disorder criteria confirmed using a self-rating questionnaire among Japanese women with depressive disorders. Biopsychosoc Med 2011;2:5:5
  7. Ross LE, Steiner M. A biopsychosocial approach to premenstrual dysphoric disorder. Psychiatr Clin North Am 2003;26:529-46
  8. Rapkin AJ, Lewis EI. Treatment of premenstrual dysphoric disorder. Womens Health (Lond) 2013;9:537-56
  9. Steiner M, Li T. Luteal phase and symptom-onset dosing of SSRIs/SNRIs in the treatment of premenstrual dysphoria: clinical evidence and rationale. CNS Drugs 2013;27:583-9
  10. Seedhom A, Mohammed E, Mahfouz E. Life style factors associated with premenstrual syndrome among el-minia university students, Egypt. Hindawi Publishing Corporation ISRN PublicHealth, 2013;1-6. 11
  11. Bertone-Johnson ER, Hankinson SE, Willett WC, et al. Adiposity and the development of premenstrual syndrome. J Womens Health (Larchmt) 2010;19:1955- 62
  12. Sepede G, Sarchione F, Matarazzo I, et al. Premenstrual dysphoric disorder without comorbid psychiatric conditions: a systematic review of therapeutic options. Clin Neuropharmacol 2016;39:241-61
  13. Pilver CE, Levy BR, Libby DJ, et al. Posttraumatic stress disorder and trauma characteristics are correlates of premenstrual dysphoric disorder. Arch Womens Ment Health 2011;14:383-93
  14. Kim D.R, Gyulai L, Freeman E.W, et al. Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Womens Ment Health 2004;7:37-47
  15. First MB, Spitzer RL, Gibbon M, et al. Structured for DSM-IV Clinical Version (SCID-I/CV) Washington D.C. American Psychiatric Press 1997
  16. Corapcıoglu A, Aydemir O, Yildiz M, et al. DSM-IV Structured Clinical Interview for